Dicerna Pharmaceuticals
DRNA
#4014
Rank
C$4.26 B
Marketcap
C$54.78
Share price
0.00%
Change (1 day)
17,631.62%
Change (1 year)

Market capitalization of Dicerna Pharmaceuticals (DRNA)

Last known market cap: C$4.26 Billion

As of November 2026 Dicerna Pharmaceuticals has a market cap of C$4.26 Billion. This makes Dicerna Pharmaceuticals the world's 4014th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dicerna Pharmaceuticals from 2014 to 2022

End of year Market Cap

Year Marketcap Change
2022C$4.04 B6.47%
2021C$3.79 B78.33%
2020C$2.12 B3.33%
2019C$2.05 B107.33%
2018C$0.99 B69.42%
2017C$0.58 B629.94%
2016C$80.32 M-76.31%
2015C$0.33 B-0.25%
2014C$0.33 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
C$223.84 B 5,144.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$337.73 B 7,813.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$472.47 B 10,970.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
C$0.80 B-81.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$27.60 B 546.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
C$8.38 B 96.41%๐Ÿ‡บ๐Ÿ‡ธ USA